Fundraising Fox

Antigenix Therapeutics

Princeton, US · Founded 2024 · Delaware corporation · 4 employees on LinkedIn

Find your way into Antigenix Therapeutics

186 people in our graph share verified history with the Antigenix Therapeutics team — schools, employers, funds. One of them is your warm intro.

Sian Cathrallunlockedknows Christopher Whitfield · together at University of Cape Town (overlapped)
×2knows the team · via Duke University - The Fuqua School of Business
×7knows the team · via Santa Clara University Leavey School of Business
×2knows the team · via Wabash College

Founders & leadership

CWChristopher Whitfield
Christopher WhitfieldinChief Executive OfficerStrategic Advisor at 2Flo Ventures

Board

KF
Kwesi Frimpong-BoatengBoard director
SH
Shaun HawkinsBoard director

Reported raises · per SEC filings

Form D private placements

$3.4M disclosed across 1 round · 2025

$3.4MraisedOct 2025 · 17 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Kwesi Frimpong-BoatengDirector
  • Christopher WhitfieldExecutive Officer, Director
  • Shaun HawkinsDirector
Offering amount
$8.4M
Amount sold
$3.4M
First sale
Oct 2025
Incorporated
Corporation, Delaware, 2024
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

In the news

Frequently asked questions

How much funding has Antigenix Therapeutics raised?
Antigenix Therapeutics has disclosed $3.4M raised across 1 round.
Where is Antigenix Therapeutics headquartered?
Antigenix Therapeutics is headquartered in Princeton, US.